Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains diadzein, genistein, and palmitoylethanolamide. Diadzein and genistein are isoflavones found in soybeans, which may possess estrogenic-like activity. Palmitoylethanolamide (PEA) is an endogenous fatty acid amide.
## Primary Indications
This combination is primarily marketed as a dietary supplement for various conditions, including menopausal symptom relief, joint health, and general well-being. It is not an FDA-approved prescription medication.
## Adult Dosing
Dosing varies widely depending on the specific product formulation. Typical daily doses range from:
* **Diadzein and Genistein:** 50-100 mg combined daily.
* **Palmitoylethanolamide (PEA):** 600-1200 mg daily, often divided into multiple doses.
Specific dosing recommendations are often product-dependent and lack robust clinical trial support for this particular combination.
## Pediatric Dosing
No established pediatric dosing. Use in children is not recommended.
## Dose Adjustments
No specific dose adjustments are established due to the lack of regulatory approval and comprehensive clinical data.
## Contraindications
* Hypersensitivity to any component of the product.
* Individuals with hormone-sensitive cancers (e.g., breast, uterine, ovarian) should use with caution or avoid, given the potential estrogenic activity of isoflavones. Consult an oncologist.
## Adverse Effects
* **Diadzein/Genistein:** Gastrointestinal upset (nausea, diarrhea, constipation), headache, dizziness. There is theoretical concern for endocrine disruption.
* **Palmitoylethanolamide (PEA):** Generally well-tolerated. May include mild gastrointestinal upset.
## Key Drug Interactions
* **Hormone Replacement Therapy (HRT):** Potential additive effects or interference.
* **Tamoxifen and other SERMs:** Isoflavones may have mixed agonist/antagonist effects, potentially altering efficacy.
* **Anticoagulants/Antiplatelets:** Isoflavones may have mild antiplatelet effects; caution with concurrent use.
* **Thyroid medications:** High intake of soy isoflavones may interfere with thyroid hormone absorption or function.
## Monitoring
* Monitor for adverse effects.
* Patients with hormone-sensitive conditions should be monitored by their oncologist.
## Clinical Pearls
* This combination is typically available as a dietary supplement, not a prescription drug.
* Efficacy and safety data for this specific combination are limited.
* Advise patients that isoflavones are not a substitute for conventional medical treatment for any condition.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature before making clinical decisions. Patient-specific factors must be considered.
